Sepsis-induced cardiac dysfunction remains a critical challenge in clinical practice, and effective therapeutic strategies are urgently needed. This study evaluated the cardioprotective potential of hydroxychloroquine (HCQ) and zinc combination therapy as both prophylactic and therapeutic interventions in a Sprague–Dawley rat model of sepsis induced by cecal ligation and puncture (CLP). Rats were assigned to five groups: Sham, Sepsis (SE), Zinc + Sepsis (Cx), HCQ + Sepsis (H), and HCQ + Zinc + Sepsis (HC). HCQ (200 mg/kg), zinc chloride (40 mg/kg), or their combination was administered after sepsis induction. Histological analysis revealed that sepsis induced marked myocardial injury, characterized by edema (p 0.05). These results indicate that combination therapy not only mitigates structural myocardial damage but also preserves endothelial integrity and modulates inflammatory responses in sepsis.In conclusion, the HCQ and zinc combination offers synergistic cardioprotective effects, providing a potential therapeutic strategy that could be easily translated into clinical practice for managing sepsis-related cardiac injury. Further studies are warranted to determine optimal dosing and clinical applicability.
Dolanbay et al. (2026) studied this question.